CRLBF
Price
$1.40
Change
-$0.04 (-2.78%)
Updated
Nov 14 closing price
118 days until earnings call
GLASF
Price
$7.99
Change
-$0.11 (-1.36%)
Updated
Nov 14 closing price
Ad is loading...

CRLBF vs GLASF

Header iconCRLBF vs GLASF Comparison
Open Charts CRLBF vs GLASFBanner chart's image
Cresco Labs
Price$1.40
Change-$0.04 (-2.78%)
Volume$687.68K
CapitalizationN/A
Glass House Brands
Price$7.99
Change-$0.11 (-1.36%)
Volume$177.28K
CapitalizationN/A
CRLBF vs GLASF Comparison Chart
Loading...
View a ticker or compare two or three
VS
CRLBF vs. GLASF commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRLBF is a Sell and GLASF is a Sell.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (CRLBF: $1.40 vs. GLASF: $7.99)
Brand notoriety: CRLBF and GLASF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CRLBF: 107% vs. GLASF: 162%
Market capitalization -- CRLBF: $501.04M vs. GLASF: $203.76M
CRLBF [@Pharmaceuticals: Other] is valued at $501.04M. GLASF’s [@Pharmaceuticals: Other] market capitalization is $203.76M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRLBF’s FA Score shows that 0 FA rating(s) are green whileGLASF’s FA Score has 0 green FA rating(s).

  • CRLBF’s FA Score: 0 green, 5 red.
  • GLASF’s FA Score: 0 green, 5 red.
According to our system of comparison, GLASF is a better buy in the long-term than CRLBF.

Price Growth

CRLBF (@Pharmaceuticals: Other) experienced а +9.38% price change this week, while GLASF (@Pharmaceuticals: Other) price change was +2.44% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +56.20%. For the same industry, the average monthly price growth was -6.16%, and the average quarterly price growth was -6.95%.

Reported Earning Dates

CRLBF is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+56.20% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
CRLBF($501M) has a higher market cap than GLASF($204M). GLASF YTD gains are higher at: 68.922 vs. CRLBF (3.260). CRLBF has higher annual earnings (EBITDA): -16.73M vs. GLASF (-24.02M). CRLBF has more cash in the bank: 88.8M vs. GLASF (13.4M). GLASF has less debt than CRLBF: GLASF (73.6M) vs CRLBF (678M). CRLBF has higher revenues than GLASF: CRLBF (822M) vs GLASF (106M).
CRLBFGLASFCRLBF / GLASF
Capitalization501M204M246%
EBITDA-16.73M-24.02M70%
Gain YTD3.26068.9225%
P/E RatioN/AN/A-
Revenue822M106M775%
Total Cash88.8M13.4M663%
Total Debt678M73.6M921%
FUNDAMENTALS RATINGS
CRLBF: Fundamental Ratings
CRLBF
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

CRLBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRLBF has been closely correlated with TCNNF. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRLBF jumps, then TCNNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRLBF
1D Price
Change %
CRLBF100%
-2.78%
TCNNF - CRLBF
75%
Closely correlated
-6.28%
TSNDF - CRLBF
75%
Closely correlated
-2.00%
CURLF - CRLBF
73%
Closely correlated
-1.79%
VRNOF - CRLBF
72%
Closely correlated
-7.29%
GTBIF - CRLBF
71%
Closely correlated
-4.21%
More

GLASF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLASF has been loosely correlated with TSNDF. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if GLASF jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLASF
1D Price
Change %
GLASF100%
-1.36%
TSNDF - GLASF
62%
Loosely correlated
-2.00%
GTBIF - GLASF
62%
Loosely correlated
-4.21%
TCNNF - GLASF
58%
Loosely correlated
-6.28%
VRNOF - GLASF
58%
Loosely correlated
-7.29%
CRLBF - GLASF
57%
Loosely correlated
-2.78%
More